<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>U-47700 - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <link rel="icon" type="image/svg+xml" href="/Dyo-s-Dubious-Domain/assets/logo.svg">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚ÜÅE<a href="/dyos-domain/depressants/">Depressants</a> ‚ÜÅE<span>U-47700</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>‚ò†ÔøΩEÔøΩEU-47700</h1>
        <h2 class="chemical-name">3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide</h2>
        
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="U-47700" 
                data-category="Depressants" 
                data-chemical="3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <span class="alt-name street">Pink</span>
            <span class="alt-name street">Pinky</span>
            <span class="alt-name street">Pink Powder</span>
            <span class="alt-name street">U4</span>
            <span class="alt-name street">U-4</span>
            <span class="alt-name chemical">AH-7921 analog</span>
            <span class="alt-name street">Synthetic Heroin</span>
            <span class="alt-name street">Research Chemical Opioid</span>
            <span class="alt-name chemical">Benzamide Opioid</span>
            <span class="alt-name street">Pink Death</span>
            <span class="alt-name street">RC Opioid</span>
            <span class="alt-name chemical">Novel Synthetic Opioid</span>
            <span class="alt-name street">Designer Opioid</span>
            <span class="alt-name chemical">NSO</span>
            <span class="alt-name street">Pink Heroin</span>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category depressant">Depressant</span>
          <span class="legal-status schedule-1">Schedule I</span>
          <span class="duration short">1-4 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/Dyo-s-Dubious-Domain/assets/substances/u-47700.jpg" alt="Pink powder of U-47700" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>Benzamide structure - novel synthetic opioid scaffold</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Typical Appearance</h4>
          <ul>
            <li><strong>Color:</strong> Pink to white crystalline powder</li>
            <li><strong>Texture:</strong> Fine powder or small crystals</li>
            <li><strong>Odor:</strong> Chemical smell, sometimes described as fishy</li>
            <li><strong>Solubility:</strong> Water-soluble, often dissolved for nasal use</li>
            <li><strong>Packaging:</strong> Small plastic bags, often unmarked</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Market Forms</h4>
          <ul>
            <li><strong>Research chemical powder:</strong> Sold online as "not for human consumption"</li>
            <li><strong>Pressed pills:</strong> Sometimes found in counterfeit prescription opioids</li>
            <li><strong>Mixed powders:</strong> Often cut with other substances</li>
            <li><strong>Nasal spray solutions:</strong> Dissolved in saline for intranasal use</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†ÔøΩEÔøΩEExtreme Contamination Risks</h4>
          <p><strong>Fentanyl contamination:</strong> Often contaminated with fentanyl increasing lethality</p>
          <p><strong>Unknown analogues:</strong> May contain U-47700 analogues with different potencies</p>
          <p><strong>Impurities:</strong> Synthesis byproducts can be toxic</p>
          <p><strong>Cross-contamination:</strong> Equipment used for multiple substances</p>
          <p><strong>Mislabeling:</strong> Often sold as other substances entirely</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-warning">
        <h4>‚ö†ÔøΩEÔøΩELETHAL DOSAGE WARNING</h4>
        <p><strong>NO SAFE DOSAGE EXISTS.</strong> U-47700 has killed experienced opioid users at doses as low as 5-10mg. Individual tolerance varies dramatically and fatal overdose is common at any dose. <strong>This substance should NEVER be used.</strong></p>
      </div>
      
      <div class="dosage-chart">
        <div class="dosage-disclaimer">
          <h4>‚ö†ÔøΩEÔøΩEINFORMATION FOR HARM REDUCTION ONLY</h4>
          <p><strong>The following information is provided solely for educational and harm reduction purposes. These doses have proven fatal for many users. NO DOSAGE IS SAFE.</strong></p>
        </div>
        
        <div class="dose-range threshold">
          <span class="range-label">Threshold (LETHAL RISK)</span>
          <span class="dose-amount">1-3mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light (HIGH DEATH RISK)</span>
          <span class="dose-amount">3-6mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common (FREQUENTLY FATAL)</span>
          <span class="dose-amount">6-15mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong (ALMOST CERTAINLY FATAL)</span>
          <span class="dose-amount">15-30mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy (GUARANTEED DEATH)</span>
          <span class="dose-amount">30mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Critical Risk Factors</h4>
        <ul>
          <li><strong>No opioid tolerance:</strong> Death likely at any dose above 1-2mg</li>
          <li><strong>Rapid onset:</strong> Effects begin within 15-30 minutes, overdose can be immediate</li>
          <li><strong>Redosing trap:</strong> Delayed onset leads to fatal redosing</li>
          <li><strong>Individual variation:</strong> Some people die at 5mg, others survive 50mg</li>
          <li><strong>Route sensitivity:</strong> IV/smoking dramatically increases death risk</li>
          <li><strong>Naloxone resistance:</strong> Higher doses of naloxone required, may not work</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>LIFE-SAVING WARNING:</strong> U-47700 has no therapeutic value and extreme lethality. Multiple experienced opioid users have died on their first use. Avoid this substance entirely.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Before Fatal Overdose)</h4>
        <div class="timeline-item">
          <span class="time">T+0:15-0:30</span>
          <span class="effect">Onset - euphoria, pain relief, respiratory depression begins</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+0:30-2:00</span>
          <span class="effect">Peak - intense euphoria, severe respiratory depression</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-4:00</span>
          <span class="effect">Plateau - continued respiratory depression, overdose risk remains high</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">Comedown - withdrawal begins, compulsive redosing urge</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÅEReported Effects (Before Death)</h4>
          <ul>
            <li>Intense euphoria and mood elevation</li>
            <li>Complete pain relief and analgesia</li>
            <li>Warm, comfortable body sensations</li>
            <li>Anxiety and stress relief</li>
            <li>Sedation and relaxation</li>
            <li>Emotional numbness</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùÅENegative Effects (Leading to Death)</h4>
          <ul>
            <li>Severe respiratory depression (primary cause of death)</li>
            <li>Cardiac arrest and cardiovascular collapse</li>
            <li>Loss of consciousness and coma</li>
            <li>Extreme nausea and vomiting</li>
            <li>Severe constipation and urinary retention</li>
            <li>Rapid tolerance and physical dependence</li>
            <li>Withdrawal syndrome more severe than morphine</li>
            <li>Fatal overdose at therapeutic-seeming doses</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>U-47700 is a potent Œº-opioid receptor agonist with a novel benzamide structure distinct from traditional opioids. It binds to Œº-opioid receptors with high affinity, producing profound analgesia and euphoria, but also life-threatening respiratory depression. Its unique structure may contribute to its extreme potency and lethality.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor">Œº-Opioid Receptor</span>
            <span class="activity">High affinity agonist</span>
            <span class="effect">Analgesia, euphoria, respiratory depression</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Œ¥-Opioid Receptor</span>
            <span class="activity">Moderate affinity</span>
            <span class="effect">Additional analgesic effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Œ∫-Opioid Receptor</span>
            <span class="activity">Low affinity</span>
            <span class="effect">Dysphoric effects at high doses</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">NOP Receptor</span>
            <span class="activity">Unknown activity</span>
            <span class="effect">Potential modulation of effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Other targets</span>
            <span class="activity">Unknown</span>
            <span class="effect">Unpredictable toxic effects</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary metabolism:</strong> Hepatic, likely via CYP enzymes (exact pathways unknown)</p>
          <p><strong>Half-life:</strong> 1-4 hours (estimated, highly variable)</p>
          <p><strong>Bioavailability:</strong> High via multiple routes</p>
          <p><strong>Peak effects:</strong> 30-60 minutes oral, faster via other routes</p>
          <p><strong>Active metabolites:</strong> Unknown, potentially toxic</p>
          <p><strong>Elimination:</strong> Primarily renal, but metabolism poorly understood</p>
        </div>

        <h4>Toxicity Mechanisms</h4>
        <div class="neurotoxicity-info">
          <p><strong>Respiratory depression:</strong> Profound suppression of brainstem respiratory centers</p>
          <p><strong>Cardiac toxicity:</strong> Direct cardiotoxic effects beyond opioid activity</p>
          <p><strong>Novel toxicity:</strong> Unique structure may cause unknown toxic effects</p>
          <p><strong>Metabolite toxicity:</strong> Breakdown products may be more toxic than parent compound</p>
          <p><strong>Organ damage:</strong> Reports of kidney and liver damage</p>
        </div>

        <h4>Unique Pharmacological Dangers</h4>
        <ul>
          <li><strong>Ultra-high potency:</strong> 7.5x more potent than morphine</li>
          <li><strong>Steep dose-response curve:</strong> Small dose increases cause disproportionate effects</li>
          <li><strong>Novel structure:</strong> Limited understanding of metabolism and toxicity</li>
          <li><strong>Naloxone resistance:</strong> May require higher naloxone doses or be completely resistant</li>
          <li><strong>Unpredictable purity:</strong> Street samples vary wildly in concentration</li>
          <li><strong>Rapid tolerance:</strong> Leads to dangerous dose escalation</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†ÔøΩEÔøΩESafety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® ABSOLUTE CRITICAL WARNINGS</h4>
          <ul>
            <li><strong>NO SAFE USE:</strong> This substance should never be used under any circumstances</li>
            <li><strong>Immediate death risk:</strong> Fatal overdose possible on first use</li>
            <li><strong>Naloxone may not work:</strong> Standard overdose reversal may be ineffective</li>
            <li><strong>No medical value:</strong> Provides no benefits that outweigh extreme death risk</li>
            <li><strong>Unpredictable potency:</strong> Impossible to dose safely</li>
            <li><strong>Contamination guarantee:</strong> Street samples always contaminated</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°ÔøΩEÔøΩEIf Encountered (Emergency Information Only)</h4>
          <ul>
            <li><strong>Call 911 immediately:</strong> Any exposure requires emergency medical care</li>
            <li><strong>Multiple naloxone doses:</strong> May require 4-8mg naloxone or more</li>
            <li><strong>Assisted ventilation:</strong> Manual breathing support may be necessary</li>
            <li><strong>Medical supervision:</strong> Hospital monitoring required for 8+ hours</li>
            <li><strong>Do not use alone:</strong> Have someone capable of calling emergency services</li>
            <li><strong>Dispose safely:</strong> Contact hazmat disposal for any remaining substance</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Universal Contraindications</h4>
        <p><strong>No one should use this substance:</strong> Any medical condition, medication use, or personal circumstance makes U-47700 use contraindicated. There are no exceptions to this warning.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏ÅEDrug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Guaranteed Fatal Combinations</h4>
          <ul>
            <li><strong>Any CNS depressants:</strong> Alcohol, benzodiazepines, barbiturates</li>
            <li><strong>Other opioids:</strong> Synergistic respiratory depression causes immediate death</li>
            <li><strong>Gabapentinoids:</strong> Dramatically increases respiratory depression</li>
            <li><strong>Antihistamines:</strong> Enhances sedation and respiratory depression</li>
            <li><strong>Muscle relaxants:</strong> Combined CNS depression is always fatal</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° Fatal Risk</h4>
          <ul>
            <li><strong>Any medication:</strong> U-47700 interactions with any drug are unpredictable</li>
            <li><strong>Stimulants:</strong> May mask respiratory depression until fatal</li>
            <li><strong>Antidepressants:</strong> Unknown interactions with serotonin systems</li>
            <li><strong>Heart medications:</strong> Potential for dangerous cardiac interactions</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† No Safe Combinations</h4>
          <ul>
            <li><strong>No substance is safe:</strong> Even vitamins may interact unpredictably</li>
            <li><strong>Medical procedures:</strong> Anesthesia interactions unknown and dangerous</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏ÅELegal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE United States</h4>
            <p>Schedule I controlled substance - maximum penalties apply</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE United Kingdom</h4>
            <p>Class A controlled drug under Misuse of Drugs Act</p>
          </div>
          <div class="jurisdiction">
            <h4>ÔøΩEÔøΩE European Union</h4>
            <p>Controlled in most member states, EU-wide monitoring</p>
          </div>
          <div class="jurisdiction">
            <h4>üåç International</h4>
            <p>WHO monitoring, increasing global control measures</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Medical Status</h4>
          <p>U-47700 has no medical applications and will never be approved for human use. Its extreme lethality and lack of therapeutic advantage over existing opioids make it unsuitable for any medical purpose.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1970s</span>
          <p>Originally synthesized by Upjohn pharmaceutical company</p>
        </div>
        <div class="history-event">
          <span class="year">1978</span>
          <p>Abandoned by Upjohn due to extreme toxicity in animal studies</p>
        </div>
        <div class="history-event">
          <span class="year">2013</span>
          <p>Resurfaces in European research chemical markets</p>
        </div>
        <div class="history-event">
          <span class="year">2014-2015</span>
          <p>First overdose deaths reported in Europe and US</p>
        </div>
        <div class="history-event">
          <span class="year">2016</span>
          <p>Major outbreak of overdose deaths, emergency scheduling begins</p>
        </div>
        <div class="history-event">
          <span class="year">2017</span>
          <p>US DEA emergency scheduling as Schedule I substance</p>
        </div>
        <div class="history-event">
          <span class="year">2018-present</span>
          <p>Continued sporadic deaths despite widespread bans</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Cultural Impact</h4>
        <p>U-47700 represents the darkest side of research chemical culture - a substance so dangerous it was abandoned by its original creators, only to resurface decades later causing widespread death and suffering. It serves as a stark warning about the risks of novel psychoactive substances.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Toxicology Studies</h4>
          <p>Research focuses on understanding the mechanisms of U-47700's extreme lethality to inform emergency treatment protocols and forensic identification.</p>
        </div>
        
        <div class="research-item">
          <h4>Overdose Treatment</h4>
          <p>Investigation into optimal naloxone dosing and alternative reversal agents for U-47700 overdoses, as standard protocols often fail.</p>
        </div>
        
        <div class="research-item">
          <h4>Detection Methods</h4>
          <p>Development of rapid testing methods for forensic identification and drug supply monitoring to prevent further deaths.</p>
        </div>
        
        <div class="research-item">
          <h4>Addiction Treatment</h4>
          <p>Limited research into treatment of U-47700 dependence, which presents unique challenges due to the substance's extreme potency.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Emergency Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Emergency Services</h4>
        <ul>
          <li><strong>Emergency:</strong> Call 911/999/112 immediately</li>
          <li><a href="https://www.poison.org/">Poison Control</a> - 1-800-222-1222</li>
          <li><strong>Naloxone:</strong> 4-8mg may be required, repeat as needed</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><strong>Hospital notification:</strong> Inform medical staff of U-47700 use</li>
          <li><strong>Extended monitoring:</strong> Required due to long half-life</li>
          <li><strong>Toxicology:</strong> Request comprehensive drug screening</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Support Resources</h4>
        <ul>
          <li><a href="https://www.samhsa.gov/">SAMHSA</a> - Addiction treatment locator</li>
          <li><strong>Professional help:</strong> Required for any exposure</li>
          <li><strong>Harm reduction:</strong> Complete avoidance is the only safe approach</li>
        </ul>
      </div>
    </div>
  </div>

</div>


    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/Dyo-s-Dubious-Domain/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    
    <!-- Only load profile.js on profile page -->
    
</body>
</html>